NCT05165992View on ClinicalTrials.gov

Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19

PHASE3UnknownINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

November 30, 2022

Study Completion Date

December 31, 2022

Conditions

COVID-19 Pneumonia

Interventions

DRUG

Nebulized Fentanyl

Administration of nebulized Fentanyl (25 μg in 5 ml of normal saline) over 15 mins, thrice daily using a traditional nebulizer. Treatment duration - 48 hours